Bausch Health Companies | VRX - Ebitda


Bausch Health Companies reported $837M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Amgen USD 5.14B 775M Dec/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Bausch Health Companies USD 837M 94M Mar/2026
Biogen USD 649.7M 76.5M Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Canopy Growth CAD -137M 134.13M Mar/2026
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Danaher USD 1.92B 204M Mar/2026
Drreddys Laboratories INR 8.63B 12.96B Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novo Nordisk DKK 34.72B 2.57B Mar/2026
Pacira USD 40.24M 1.53M Mar/2026
Perrigo USD 141.6M 1.34B Mar/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 90.82M 3.99M Dec/2025
Supernus Pharmaceuticals USD 29.23M 19.27M Mar/2026
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026
Zoetis USD 939M 101M Dec/2025